Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T18:22:15.637Z.
Calculation as of: 2026-10-06T18:22:15.637Z.
Quote observation: 2026-10-06T18:19:41.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 82cee4a6010f8650e239c44e6fa86f6cad5a1cacb0b867e980d6d40a64789328
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Nautilus Biotechnolgy, Inc.
Market Cap
$234.79M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$234.90M
EV/EBITDA Ratio
N/A
TTM Avg
5.07x
3Y Avg
4.97x
5Y Avg
6.62x
Market Cap
$235.32M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$231.69M
EV/EBITDA Ratio
N/A
TTM Avg
133.55x
3Y Avg
183129.66x
5Y Avg
183129.66x
Market Cap
$235.97M
EV/EBITDA Ratio
18.61x
TTM Avg
9.66x
3Y Avg
8.05x
5Y Avg
8.98x
Market Cap
$237.35M
EV/EBITDA Ratio
N/A
TTM Avg
21.13x
3Y Avg
83.14x
5Y Avg
83.14x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nautilus Biotechnolgy, Inc. (NAUT) | $234.79M | N/A | N/A | N/A | N/A |
| SIGA Technologies, Inc. (SIGA)vs › | $234.90M | N/A | 5.07x | 4.97x | 6.62x |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $235.32M | N/A | N/A | N/A | N/A |
| MacroGenics, Inc. (MGNX)vs › | $231.69M | N/A | 133.55x | 183129.66x | 183129.66x |
| InflaRx N.V. (IFRX)vs › | $235.67M | N/A | N/A | N/A | N/A |
| Utah Medical Products, Inc. (UTMD)vs › | $235.97M | 18.61x | 9.66x | 8.05x | 8.98x |
| BioAge Labs Inc. (BIOA)vs › | $236.06M | N/A | N/A | N/A | N/A |
| Biodesix, Inc. (BDSX)vs › | $230.51M | N/A | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $237.35M | N/A | 21.13x | 83.14x | 83.14x |
| High Tide Inc. (HITI)vs › | $237.69M | 12.82x | 20.89x | 46.57x | 889.74x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
